In the latest issue of InforMS, we explore what we know about the potential benefits and harms of the existing therapies for multiple sclerosis, how we think today about the risks from the MS disease process, and what we know about how people assess risk. Patricia Daily , LCSW.
Risky Business: Exploring How We Assess and Live with Risk and MS
Home » Posts » Risky Business: Exploring How We Assess and Live with Risk and MS